Please login to the form below

Not currently logged in
Email:
Password:

Actavis expands in Ireland

Generics manufacturer Actavis plans to boost its presence in Ireland, creating up to 25 new jobs and launching more than 120 generic drugs

Generics manufacturer Actavis plans to boost its presence in Ireland, creating up to 25 new jobs over the next five years and launching more than 120 generic drugs in the country. The company's chemotherapy treatment, gemcitabine, was made available to the Irish market on March 9 as Eli Lilly's patent for Gemzar expired in the European Union. 

With headquarters in Iceland the Actavis group employs about 11,000 people and has a presence in 40 countries. The group continues to grow and has acquired more than 20 companies in the past seven years including the human generics business of Alpharma in December 2005.

In a statement Tony Hynds, managing director of Actavis Ireland said: "Over the next five years, we plan to rapidly expand our offering in Ireland in all channels – hospital-specific, prescription and over-the-counter medicines." 

In Febuary 2009 the Irish Government published the report Economies in Drug Usage in the Irish Healthcare Setting which promotes generic prescribing as part of a strategy to reduce the country's healthcare spend.

17th March 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

DNA
Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...

Infographics